KLRK1 and neoplasm: Yet, common features of the HCC model, the late-arising prostate tumours and the low-dose MCA-induced tumours model are: (i) the slow pace of tumour progression (ii) the high level of immune cells infiltrating the tumours and (iii) the sustained expression of NKG2D ligands.